QuiremSpheres
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for QuiremSpheres, covering 2024-07-05 to 2025-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma [NA]